KPWS
CRL icon

Kestra Private Wealth Services’s Charles River Laboratories CRL Stock Holding History

Kestra Private Wealth Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Sell
2,851
-13
-0.5% -$2.31K 0.01% 1113
2026
Q1 		$494K Sell
2,864
-145
-5% -$26.9K 0.01% 1213
2025
Q4 		$600K Buy
3,009
+145
+5% +$26.3K 0.01% 1065
2025
Q3 		$448K Sell
2,864
-8
-0.3% -$1.27K 0.01% 1157
2025
Q2 		$436K Buy
2,872
+943
+49% +$126K 0.01% 1101
2025
Q1 		$290K Sell
1,929
-115
-6% -$19.3K ﹤0.01% 1220
2024
Q4 		$377K Buy
2,044
+136
+7% +$26.2K 0.01% 1048
2024
Q3 		$376K Buy
1,908
+19
+1% +$3.95K 0.01% 1000
2024
Q2 		$390K Sell
1,889
-16
-0.8% -$3.63K 0.01% 933
2024
Q1 		$516K Buy
1,905
+10
+0.5% +$2.39K 0.01% 784
2023
Q4 		$448K Buy
1,895
+95
+5% +$18.7K 0.01% 773
2023
Q3 		$353K Buy
1,800
+236
+15% +$48.5K 0.01% 794
2023
Q2 		$329K Sell
1,564
-31
-2% -$6.17K 0.01% 788
2023
Q1 		$322K Buy
1,595
+78
+5% +$17.7K 0.01% 760
2022
Q4 		$331K Buy
+1,517
New +$331K 0.02% 644
2022
Q3 		– Sell
-2,179
Closed -$466K – 920
2022
Q2 		$466K Sell
2,179
-16
-0.7% -$3.91K 0.03% 528
2022
Q1 		$623K Sell
2,195
-2,566
-54% -$791K 0.03% 505
2021
Q4 		$1.79M Buy
4,761
+52
+1% +$20.2K 0.09% 248
2021
Q3 		$1.94M Sell
4,709
-80
-2% -$33.2K 0.11% 205
2021
Q2 		$1.77M Sell
4,789
-62
-1% -$20.7K 0.11% 214
2021
Q1 		$1.41M Sell
4,851
-1,618
-25% -$450K 0.1% 228
2020
Q4 		$1.61M Sell
6,469
-100
-2% -$23.8K 0.12% 192
2020
Q3 		$1.49M Buy
+6,569
New +$1.36M 0.13% 176

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Kestra Private Wealth Services's CRL Position: Q2 2026 in Review

Kestra Private Wealth Services reduced its Charles River Laboratories (CRL) stake by 0.45% in Q2 2026, selling an estimated $2.31K and leaving 2,851 shares worth $647K. The position accounts for 0.01% of the portfolio, ranked #1113.

Kestra Private Wealth Services first reported a position in CRL in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.94M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Kestra Private Wealth Services held 2,851 shares of Charles River Laboratories worth $647K as of Q2 2026.
  • Kestra Private Wealth Services sold 13 Charles River Laboratories shares in Q2 2026, an estimated $2.31K.
  • Charles River Laboratories made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1113 holding.
  • Kestra Private Wealth Services first reported a position in Charles River Laboratories in Q3 2020 and has held it in 23 quarters since.
  • Kestra Private Wealth Services's Charles River Laboratories position peaked at $1.94M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.